POS0729 DIFFERENCES BETWEEN GLUCOCORTICOIDS, CONVENTIONAL DMARDS AND TOCILIZUMAB IN ACHIEVING DISEASE REMISSION AND IN PREVENTING THE PROGRESSION OF DAMAGE IN GIANT CELL ARTERITIS PATIENTS
Author:
Davanzo F.,Iorio L.,Codirenzi M.,Padoan R.,Doria A.
Publisher
BMJ Publishing Group Ltd and European League Against Rheumatism